JOHN K. CLARKE

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JOHN K. CLARKE:

Company Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC Director Stock Option (right to buy) 24,000 22 May 2024 Direct

Insider Reports Filed by JOHN K. CLARKE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATYR aTYR PHARMA INC 22 May 2024 1 $0 4 Director 23 May 2024, 19:30
ATYR aTYR PHARMA INC 17 May 2023 1 $0 4 Director 19 May 2023, 16:23
ATYR aTYR PHARMA INC 26 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:54
ATYR aTYR PHARMA INC 26 Apr 2022 1 $0 4 Director 28 Apr 2022, 19:39
ATYR aTYR PHARMA INC 21 May 2021 1 -$10,850 4 Director 25 May 2021, 21:05